Induction of bone formation by Escherichia coli-expressed recombinant human bone morphogenetic protein-2 using block-type macroporous biphasic calcium phosphate in orthotopic and ectopic rat models

Journal of Periodontal Research

Volumn 46, Issue 6, 2011, Pages 682-690

  Park, J C ^a   So, S S ^a   Jung, I H ^a   Yun, J H ^b   Choi, S H ^a   Cho, K S ^a   Kim, C S ^a  

^a Yonsei University College of Dentistry   (South Korea)

^b Inha University School of Medicine   (South Korea)

Author keywords

Animal model; Bone grafting; Growth factors

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; HYDROXYAPATITE; HYDROXYAPATITE BETA TRICALCIUM PHOSPHATE; HYDROXYAPATITE-BETA TRICALCIUM PHOSPHATE; RECOMBINANT PROTEIN; TISSUE SCAFFOLD;

ADIPOGENESIS; ANIMAL; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; BONE DEVELOPMENT; BONE PROSTHESIS; DRUG EFFECT; ESCHERICHIA COLI; HUMAN; MALE; METABOLISM; POROSITY; RAT; SKULL; SPRAGUE DAWLEY RAT; SUBCUTANEOUS TISSUE;

ADIPOGENESIS; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE SUBSTITUTES; ESCHERICHIA COLI; HUMANS; HYDROXYAPATITES; MALE; MODELS, ANIMAL; OSTEOGENESIS; POROSITY; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SKULL; SUBCUTANEOUS TISSUE; TISSUE SCAFFOLDS;

EID: 80054933585     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01390.x     Document Type: Article

References (27)

1. Seeherman H, Wozney JM. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005;16:329-345.
2. Haidar ZS, Hamdy RC, Tabrizian M Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: current challenges in BMP delivery. Biotechnol Lett 2009;31:1817-1824.
3. Schliephake H, Weich HA, Dullin C, Gruber R, Frahse S. Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid - an experimental study in rats. Biomaterials 2008;29:103-110.
4. Kim CS, Kim JI, Kim J et al. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2005;26:2501-2507.
5. Hong SJ, Kim CS, Han DK et al. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials 2006;27:3810-3816.
6. Schwarz F, Rothamel D, Herten M, Ferrari D, Sager M, Becker J. Lateral ridge augmentation using particulated or block bone substitutes biocoated with rhGDF-5 and rhBMP-2: an immunohistochemical study in dogs. Clin Oral Implants Res 2008;19:642-652.
7. Boyne PJ, Lilly LC, Marx RE et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 2005;63:1693-1707.
8. Fiorellini JP, Howell TH, Cochran D et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 2005;76:605-613.
9. Triplett RG, Nevins M, Marx RE. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 2009;67:1947-1960.
10. Le Nihouannen D, Guehennec LL, Rouillon T et al. Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. Biomaterials 2006;27:2716-2722.
11. Le Nihouannen D, Saffarzadeh A, Gauthier O et al. Bone tissue formation in sheep muscles induced by a biphasic calcium phosphate ceramic and fibrin glue composite. J Mater Sci Mater Med 2008;19:667-675.
12. Lee JH, Jung UW, Kim CS, Choi SH, Cho KS. Histologic and clinical evaluation for maxillary sinus augmentation using macroporous biphasic calcium phosphate in human. Clin Oral Implants Res 2008;19:767-771.
13. Bessho K, Konishi Y, Kaihara S, Fujimura K, Okubo Y, Iizuka T. Bone induction by Escherichia coli-derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2. Br J Oral Maxillofac Surg 2000;38:645-649.
14. Kubler NR, Reuther JF, Faller G, Kirchner T, Ruppert R, Sebald W. Inductive properties of recombinant human BMP-2 produced in a bacterial expression system. Int J Oral Maxillofac Surg 1998;27:305-309.
15. Vallejo LF, Brokelmann M, Marten S et al. Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. J Biotechnol 2002;94:185-194.
16. Zhao M, Chen D. Expression of rhBMP-2 in Escherichia coli and its activity in inducing bone formation. In: Lindholm TS, ed. Advances in Skeletal Reconstruction Using Bone Morphogenetic Proteins. New Jersey: World Scientific, 2002:456.
17. Choi KH, Moon K, Kim SH, Yun JH, Jang KL, Cho KS. Purification and biological activity of recombinant human bone morphogenetic protein-2 produced by E. coli expression system. J Korean Acad Periodontol 2008;38:41-49.
18. Ruppert R, Hoffmann E, Sebald W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 1996;237:295-302.
19. Lee JH, Kim CS, Choi KH et al. The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli. Biomaterials 2010;31:3512-3519.
20. Tabandeh F, Shojaosadati SA, Zomorodipour A, Khodabandeh M, Sanati MH, Yakhchali B. Heat-induced production of human growth hormone by high cell density cultivation of recombinant Escherichia coli. Biotechnol Lett 2004;26:245-250.
21. Barboza EP, Duarte ME, Geolas L, Sorensen RG, Riedel GE, Wikesjo UM. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 2000;71:488-496.
22. Yu YY, Lieu S, Lu C, Colnot C. Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone 2010;47:65-73.
23. Shockley KR, Lazarenko OP, Czernik PJ, Rosen CJ, Churchill GA, Lecka-Czernik B. PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J Cell Biochem 2009;106:232-246.
24. Kang Q, Song WX, Luo Q et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 2009;18:545-559.
25. Akune T, Ohba S, Kamekura S et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004;113:846-855.
26. Ali AA, Weinstein RS, Stewart SA, Parfitt AM, Manolagas SC, Jilka RL. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 2005;146:1226-1235.
27. Soroceanu MA, Miao D, Bai XY, Su H, Goltzman D, Karaplis AC. Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis. J Endocrinol 2004;183:203-216.